Selection of natural health products for clinical trials: A preclinical template

Canadian Journal of Physiology and Pharmacology

Volumn 87, Issue 5, 2009, Pages 371-378

  Vohra, S ^a   Adams, D ^a   Hudson, J B ^b   Moore, J A ^c   Vimalanathan, S ^b   Sharma, M ^b   Burt, A J ^d   Lamont, E ^d   Lacaze, N ^a   Arnason, J T ^d   Lee, T D G ^c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Clinical trials; Colds and flu; Echinacea; Phytochemistry

Indexed keywords

ALKAMIDE DERIVATIVE; AMIDE; CAFTARIC ACID; CICHORIC ACID; CYNARINE; ECHINACEA ANGUSTIFLORA EXTRACT; ECHINACEA PURPUREA EXTRACT; ECHINACOSIDE; HYDROXYACID; POLYSACCHARIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ECHINACEA; ECHINACEA ANGUSTIFLORA; ECHINACEA PURPUREA; FEMALE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; MACROPHAGE; MOUSE; NONHUMAN; PHYTOCHEMISTRY; PRIORITY JOURNAL;

ANIMALS; CLINICAL TRIALS AS TOPIC; ECHINACEA; HUMANS; INTERLEUKIN-6; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; PLANT EXTRACTS;

EID: 65949099106     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y09-021     Document Type: Article

References (19)

1. Barnes, P.M., Powell-Griner, E., McFann, K., and Nahin, R.L. 2004. Complementary and alternative medicine use among adults: United States 2002. CDC Advance Data from Vital and Health Statistics. No. 343. National Center for Health Statistics. Hyattsville, Maryland. Available from http://www.cdc.gov/ nchs/data/ad/ad343.pdf [accessed 3 Apr 2009].
2. Bauer, R. 1998. Echinacea: biological effects and active principals. In Phytomedicines of Europe: chemistry and biological activity. ACS symposium series 691. Edited by L.D. Lawson and R. Bauer. American Chemical Society, Washington, D.C. pp. 140-157.
3. Bergeron, C., Livesey, J., Awang, D., Arnason, J.T., Rana, J., Baum, B., and Letchamo, W. 2000. A quantitative HPLC method for the quality assurance of Echinacea products on the North American market. Phytochem. Anal. 11: 207-215. doi:10.1002/1099- 1565(200007/08)11:4〈207::AID-PCA519〉3.0.CO;2-T.
4. Binns, S.E., Livesey, J.F., Arnason, J.T., and Baum, B.R. 2002. Phytochemical variation in Echinacea from roots and flowerheads of wild and cultivated populations. J. Agric. Food Chem. 50: 3673-3687. doi:10.1021/ jf011439t.
5. Brovelli, E.A., Rua, D., Roh-Schmidt, H., Chandra, A., Lamont, E., and Noratto, G.D. 2005. Human gene expression as a tool to determine horticultural maturity in a bioactive plant. J. Agric. Food Chem. 53: 8156-8161. doi:10.1021/jf0505372.
6. Burger, R.A., Torres, A.R., Warren, R.P., Caldwell, V.D., and Hughes, B.D. 1997. Echinacea-induced cytokine production by human macrophages. Int. J. Immunopharmacol. 19: 371-379. doi:10.1016/S0192-0561(97)00061-1.
7. Foster, B., Drouin, C., Krantis, A., Panahi, M., Franovi, A., Burczynski, F., et al. 2005. Chemical marker profile and biological effects of natural products containing Echinacea. J. Complement. Integr. Med. 2(1): article 11. doi: 10.2202/1553-3840.1026.
8. Gertsch, J., Schoop, R., Kuenzle, U., and Suter, A. 2004. Echinacea alkamides modulate TNF-α gene expression via cannabinoid receptor CB2 and multiple signal transduction pathways. FEBS Lett. 577: 563-568. doi:10.1016/j.febslet.2004.10.064.
9. Goel, V., Lovlin, R., Barton, R., Lyon, R., Bauer, R., Lee, T.D.G., and Basu, T.K. 2004. Efficacy of a standardized Echinacea preparation (Echinilin™) for the treatment of the common cold: a randomized, double-blind, placebo-controlled trial. J. Clin. Pharm. Ther. 29: 75-83. doi:10.1111/j.1365-2710.2003.00542.x.
10. Hudson, J., Vimalanathan, S., Kang, L., Treyvaud Amiguet, V., Livesey, J., and Arnason, J.T. 2005. Characterization of antiviral activities in Echinacea root preparations. Pharmacol. Biol. 43: 790-796. doi:10.1080/ 13880200500408491.
11. Linde, K., Barrett, B., Wölkart, K., Bauer, R., and Melchart, D. 2006. Echinacea for preventing and treating the common cold. Cochrane Database Syst. Rev. CD000530. doi:10.1002/14651858.CD000530.pub2.
12. Raduner, S., Majewska, A., Chen, J.Z., Xie, X.Q., Hamon, J., Faller, B., et al. 2006. Alkamides from Echinacea are a new class of cannabinomimetics. J. Biol. Chem. 281: 14192-14206. doi:10.1074/jbc.M601074200.
13. Randolph, R.K., Gellenbeck, K., Stonebrook, K., Brovelli, E., Qian, Y., Bankaitis-Davis, D., and Cheronis, J. 2003. Regulation of human gene expression as influenced by a commercial blended Echinacea product: preliminary studies. Exp. Biol. Med. 228(9): 1051-1056.
14. Rininger, J.A., Kickner, S., Chigurupati, P., McLean, A., and Franck, Z. 2000. Immunopharmacological activity of Echinacea preparations following simulated digestion on murine macrophages and human peripheral blood cells. J. Leukoc. Biol. 68: 503-510.
15. Shah, S.A., Sander, S., White, C.M., Rinaldi, M., and Coleman, C.I. 2007. Evaluation of Echinacea for the prevention and treatment of the common cold: a meta-analysis. Lancet Infect. Dis. 7: 473-480. doi:10.1016/S1473-3099(07)70160- 3.
16. Sharma, M., Arnason, J.T., Burt, A., and Hudson, J.B. 2006a. Echinacea extracts modulate the pattern of chemokine and cytokine secretion in rhinovirus-infected and uninfected epithelial cells. Phytother. Res. 20: 147-152. doi:10.1002/ptr.1824.
17. Sharma, M., Arnason, J.T., and Hudson, J.B. 2006b. Echinacea extracts modulate the production of multiple transcription factors in uninfected cells and rhinovirus-infected cells. Phytother. Res. 20: 1074-1079. doi:10.1002/ptr.1998.
18. Sullivan, A.M., Laba, J.G., Moore, J.A., and Lee, T.D.G. 2008. Echinacea induced macrophage activation. Immunopharmacol. Immunotoxicol. 30: 553-574. doi:10.1080/08923970802135534.
19. Vimalanathan, S., Kang, L., Treyvaud Amiguet, V., Livesey, J., Arnason, J.T., and Hudson, J.B. 2005. Echinacea purpurea aerial parts contain multiple antiviral compounds. Pharmacol. Biol. 43: 740-745. doi:10.1080/ 13880200500406354.